{
  "pmid": "40074309",
  "title": "Synergistic antibacterial effects of pinaverium bromide and oxacillin against Staphylococcus epidermidis.",
  "abstract": "OBJECTIVES: Staphylococcus epidermidis (S. epidermidis) adheres to the surface of medical devices, forming highly drug-resistant biofilms, which has made the development of novel antibacterial agents against S. epidermidis and its biofilms a key research focus. By drug repurposing, this study aims to explore the combinational antimicrobial effects between pinaverium bromide (PVB), a L-type calcium channel blocker, and oxacillin (OXA) against S. epidermidis. METHODS: Clinical isolates of S. epidermidis were collected from January to September 2022 at the Department of Clinical Laboratory of the Third Xiangya Hospital, Central South University. The minimal inhibitory concentrations (MICs) of PVB and OXA were determined using the broth microdilution method. Checkerboard assays and time-kill curves were performed to assess the fractional inhibitory concentration index and synergistic bactericidal efficiency of the drug combination. Resistance selection assays evaluated PVB's ability to inhibit the development of OXA resistance. Biofilm eradication assays, combined with confocal laser scanning microscopy (CLSM) and the persister cell quantification, were conducted to evaluate the effect of PVB and OXA on drug-resistant biofilms and persister cells. The mechanisms of PVB action were further investigated using transmission electronic microscopy (TEM), reactive oxygen species (ROS) quantification, and ATP quantification. RESULTS: The MICs of PVB and OXA against the standard strain S. epidermidis RP62A were both 8 \u03bcg/mL. Checkerboard assays showed that the fractional inhibitory concentration index (FICI) for the combination was 0.250 0 for RP62A and ranged from 0.187 5 to 0.500 0 for clinical isolates, indicating synergistic effects. Resistance selection assays demonstrated that PVB not only failed to induce resistance but also effectively inhibited the development of OXA resistance. The combination of 1\u00d7MIC of PVB and OXA reduced biofilm biomass (A570 nm) from (2.36\u00b10.46) to (1.12\u00b10.39) (t=3.504, P=0.02). CLSM revealed significant biofilm structural disruption and an increased proportion of dead bacteria. Additionally, after 4 hours of treatment, the total persister cell count was reduced from lg(7.73\u00b10.21) to lg(2.79\u00b10.43) (t=4.143, P=0.014). Synergistic biofilm eradication was further confirmed in clinical isolates. TEM revealed that PVB caused significant bacterial structural damage. The combination of OXA and PVB significantly induced ROS production, increasing the relative fluorescence intensity from (30 000.00\u00b12 000.00) to (45 666.67\u00b12 081.67) (t=10.68, P<0.001), and markedly reduced ATP generation, lowering the relative fluorescence intensity form (565.00\u00b133.18) to (205.67\u00b135.23) (t=4.932, P=0.003). CONCLUSIONS: The combination of PVB and OXA exhibits significant synergistic antimicrobial activity against S. epidermidis, its biofilms, and persister cells. This combination holds promise as a potential alternative therapy for biofilm-associated infections caused by S. epidermidis. \u76ee\u7684: \u8868\u76ae\u8461\u8404\u7403\u83cc\u80fd\u9ecf\u9644\u4e8e\u533b\u7597\u5668\u68b0\u8868\u9762\u5f62\u6210\u9ad8\u8010\u836f\u7684\u751f\u7269\u88ab\u819c\uff0c\u9488\u5bf9\u8868\u76ae\u8461\u8404\u7403\u83cc\u53ca\u5176\u751f\u7269\u88ab\u819c\u7684\u65b0\u578b\u6297\u83cc\u836f\u7269\u7814\u53d1\u5df2\u6210\u4e3a\u7814\u7a76\u70ed\u70b9\u3002\u672c\u7814\u7a76\u901a\u8fc7\u836f\u7269\u91cd\u65b0\u5229\u7528\uff0c\u63a2\u8ba8L\u578b\u9499\u79bb\u5b50\u901a\u9053\u963b\u65ad\u5242\u5339\u7ef4\u6eb4\u94f5(pinaverium bromide\uff0cPVB)\u4e0e\u82ef\u5511\u897f\u6797(oxacillin\uff0cOXA)\u8054\u5408\u4f7f\u7528\u5bf9\u8868\u76ae\u8461\u8404\u7403\u83cc\u7684\u6297\u83cc\u4f5c\u7528\u3002\u65b9\u6cd5: \u8868\u76ae\u8461\u8404\u7403\u83cc\u4e34\u5e8a\u83cc\u682a\u4e8e2022\u5e741\u81f39\u6708\u6536\u96c6\u4e8e\u4e2d\u5357\u5927\u5b66\u6e58\u96c5\u4e09\u533b\u9662\u68c0\u9a8c\u79d1\u3002\u901a\u8fc7\u5fae\u91cf\u8089\u6c64\u7a00\u91ca\u5b9e\u9a8c\u68c0\u6d4bPVB\u548cOXA\u7684\u6700\u4f4e\u6291\u83cc\u6d53\u5ea6(minimal inhibitory concentration\uff0cMIC)\u3002\u68cb\u76d8\u7a00\u91ca\u5b9e\u9a8c\u548c\u65f6\u95f4-\u6740\u83cc\u66f2\u7ebf\u7528\u4e8e\u68c0\u6d4bPVB\u548cOXA\u8054\u7528\u7684\u534f\u540c\u6291\u83cc\u6307\u6570\u548c\u534f\u540c\u6740\u83cc\u6548\u7387\u3002\u8010\u836f\u7b5b\u9009\u5b9e\u9a8c\u7528\u4e8e\u68c0\u6d4bPVB\u6291\u5236OXA\u8010\u836f\u6027\u5f62\u6210\u7684\u80fd\u529b\u3002\u751f\u7269\u88ab\u819c\u6e05\u9664\u5b9e\u9a8c\u7ed3\u5408\u6fc0\u5149\u5171\u805a\u7126\u663e\u5fae\u955c\u89c2\u5bdf\u548c\u6301\u7559\u83cc\u8ba1\u6570\u5b9e\u9a8c\u7528\u4e8e\u68c0\u6d4bPVB\u4e0eOXA\u8054\u7528\u5bf9\u8868\u76ae\u8461\u8404\u7403\u83cc\u9ad8\u8010\u836f\u6027\u751f\u7269\u88ab\u819c\u548c\u6301\u7559\u83cc\u7684\u6297\u83cc\u4f5c\u7528\u3002\u901a\u8fc7\u900f\u5c04\u7535\u955c\u3001\u6d3b\u6027\u6c27(reactive oxygen species\uff0cROS)\u5b9a\u91cf\u5b9e\u9a8c\u548cATP\u5b9a\u91cf\u5b9e\u9a8c\u63a2\u8ba8PVB\u7684\u4f5c\u7528\u673a\u5236\u3002\u7ed3\u679c: PVB\u548cOXA\u5bf9\u8868\u76ae\u8461\u8404\u7403\u83cc\u6807\u51c6\u83cc\u682aRP62A\u7684MIC\u5747\u4e3a8 \u03bcg/mL\u3002\u68cb\u76d8\u7a00\u91ca\u5b9e\u9a8c\u663e\u793aPVB\u4e0eOXA\u8054\u7528\u5bf9\u8868\u76ae\u8461\u8404\u7403\u83cc\u6807\u51c6\u83cc\u682aRP62A\u7684\u534f\u540c\u6291\u83cc\u6307\u6570\u4e3a0.250 0\uff0c\u5bf9\u4e34\u5e8a\u5206\u79bb\u83cc\u682a\u7684\u534f\u540c\u6291\u83cc\u6307\u6570\u4e3a0.187 5~0.500 0\uff0c\u63d0\u793a\u5747\u4e3a\u534f\u540c\u4f5c\u7528\u3002\u8010\u836f\u7b5b\u9009\u5b9e\u9a8c\u53d1\u73b0PVB\u4e0d\u4ec5\u4e0d\u4f1a\u4ea7\u751f\u8010\u836f\uff0c\u8fd8\u80fd\u6709\u6548\u6291\u5236OXA\u4ea7\u751f\u8010\u836f\u30021\u00d7MIC\u7684PVB\u548cOXA\u8054\u7528\u65f6\uff0c\u53ef\u4f7f\u751f\u7269\u88ab\u819c\u7684\u5438\u5149\u5ea6(A570 nm)\u4ece(2.36\u00b10.46)\u51cf\u5c11\u5230(1.12\u00b10.39) (t=3.504\uff0cP=0.02)\u3002\u901a\u8fc7\u6fc0\u5149\u5171\u805a\u7126\u663e\u5fae\u955c\u89c2\u5bdf\u53ef\u77e5\uff0cPVB\u548cOXA\u8054\u7528\u8fd8\u53ef\u660e\u663e\u7834\u574f\u751f\u7269\u88ab\u819c\u7684\u7ed3\u6784\uff0c\u4f7f\u6b7b\u4ea1\u7ec6\u83cc\u7684\u6bd4\u4f8b\u589e\u52a0\u3002\u540c\u65f6\uff0c1\u00d7MIC\u7684PVB\u548cOXA\u4f5c\u7528\u4e8e\u6301\u7559\u83cc4 h\uff0c\u53ef\u4f7f\u6301\u7559\u83cc\u7684\u603b\u91cf\u4ecelg(7.73\u00b10.21)\u51cf\u5c11\u5230lg(2.79\u00b10.43)(t=4.143\uff0cP=0.014)\u3002\u6b64\u5916\uff0cPVB\u8054\u7528OXA\u7684\u534f\u540c\u6297\u751f\u7269\u88ab\u819c\u6548\u679c\u5728\u4e34\u5e8a\u83cc\u682a\u4e2d\u5f97\u5230\u8fdb\u4e00\u6b65\u9a8c\u8bc1\u3002\u900f\u5c04\u7535\u955c\u89c2\u5bdf\u53d1\u73b0PVB\u53ef\u4f7f\u7ec6\u83cc\u7ed3\u6784\u660e\u663e\u7834\u574f\u3002OXA\u4e0ePVB\u8054\u7528\u53ef\u663e\u8457\u8bf1\u5bfc\u7ec6\u83cc\u4ea7\u751fROS\uff0c\u4f7fROS\u76f8\u5bf9\u8367\u5149\u5f3a\u5ea6\u4ece(30 000.00\u00b12 000.00)\u5347\u9ad8\u5230(45 666.67\u00b12 081.67) (t=10.68\uff0cP<0.001)\u3002PVB\u548cOXA\u8054\u7528\u8fd8\u53ef\u663e\u8457\u964d\u4f4eATP\u7684\u751f\u6210\uff0c\u4f7fATP\u63a2\u9488\u76f8\u5bf9\u8367\u5149\u5f3a\u5ea6\u4ece(565.00\u00b133.18)\u51cf\u5c11\u5230(205.67\u00b135.23) (t=4.932\uff0cP=0.003)\u3002\u7ed3\u8bba: PVB\u8054\u7528OXA\u5bf9\u8868\u76ae\u8461\u8404\u7403\u83cc\u53ca\u5176\u751f\u7269\u88ab\u819c\u548c\u6301\u7559\u83cc\u5177\u6709\u663e\u8457\u7684\u534f\u540c\u6297\u83cc\u4f5c\u7528\uff0c\u6709\u671b\u6210\u4e3a\u96be\u6cbb\u6027\u8868\u76ae\u8461\u8404\u7403\u83cc\u751f\u7269\u88ab\u819c\u76f8\u5173\u611f\u67d3\u7684\u66ff\u4ee3\u836f\u7269\u3002. OBJECTIVE: Staphylococcus epidermidis (S. epidermidis) adheres to the surface of medical devices, forming highly drug-resistant biofilms, which has made the development of novel antibacterial agents against S. epidermidis and its biofilms a key research focus. By drug repurposing, this study aims to explore the combinational antimicrobial effects between pinaverium bromide (PVB), a L-type calcium channel blocker, and oxacillin (OXA) against S. epidermidis. METHODS: Clinical isolates of S. epidermidis were collected from January to September 2022 at the Department of Clinical Laboratory of the Third Xiangya Hospital, Central South University. The minimal inhibitory concentrations (MICs) of PVB and OXA were determined using the broth microdilution method. Checkerboard assays and time-kill curves were performed to assess the fractional inhibitory concentration index and synergistic bactericidal efficiency of the drug combination. Resistance selection assays evaluated PVB\u2019s ability to inhibit the development of OXA resistance. Biofilm eradication assays, combined with confocal laser scanning microscopy (CLSM) and the persister cell quantification, were conducted to evaluate the effect of PVB and OXA on drug-resistant biofilms and persister cells. The mechanisms of PVB action were further investigated using transmission electronic microscopy (TEM), reactive oxygen species (ROS) quantification, and ATP quantification. RESULTS: The MICs of PVB and OXA against the standard strain S. epidermidis RP62A were both 8 \u03bcg/mL. Checkerboard assays showed that the fractional inhibitory concentration index (FICI) for the combination was 0.250 0 for RP62A and ranged from 0.187 5 to 0.500 0 for clinical isolates, indicating synergistic effects. Resistance selection assays demonstrated that PVB not only failed to induce resistance but also effectively inhibited the development of OXA resistance. The combination of 1\u00d7MIC of PVB and OXA reduced biofilm biomass (A570 nm) from (2.36\u00b10.46) to (1.12\u00b10.39) (t=3.504, P=0.02). CLSM revealed significant biofilm structural disruption and an increased proportion of dead bacteria. Additionally, after 4 hours of treatment, the total persister cell count was reduced from lg(7.73\u00b10.21) to lg(2.79\u00b10.43) (t=4.143, P=0.014). Synergistic biofilm eradication was further confirmed in clinical isolates. TEM revealed that PVB caused significant bacterial structural damage. The combination of OXA and PVB significantly induced ROS production, increasing the relative fluorescence intensity from (30 000.00\u00b12 000.00) to (45 666.67\u00b12 081.67) (t=10.68, P<0.001), and markedly reduced ATP generation, lowering the relative fluorescence intensity form (565.00\u00b133.18) to (205.67\u00b135.23) (t=4.932, P=0.003). CONCLUSION: The combination of PVB and OXA exhibits significant synergistic antimicrobial activity against S. epidermidis, its biofilms, and persister cells. This combination holds promise as a potential alternative therapy for biofilm-associated infections caused by S. epidermidis.",
  "journal": "Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences",
  "year": "2024",
  "authors": [
    "Yuan L",
    "She P"
  ],
  "doi": "10.11817/j.issn.1672-7347.2024.240109",
  "mesh_terms": [
    "Staphylococcus epidermidis",
    "Oxacillin",
    "Biofilms",
    "Anti-Bacterial Agents",
    "Microbial Sensitivity Tests",
    "Drug Synergism",
    "Humans"
  ],
  "full_text": "## \u4e3b\u8981\u4eea\u5668\u4e0e\u8bd5\u5242\n2\u2019\uff0c7\u2019-\u4e8c\u6c2f\u8367\u5149\u7d20\u4e8c\u4e59\u9178\u916f(H2DCFDA)\u8367\u5149\u63a2\u9488\u3001PVB\u3001OXA\u3001\u4e8c\u7532\u57fa\u4e9a\u781c(dimethyl sulfoxide\uff0cDMSO)\u548c\u7ed3\u6676\u7d2b\u67d3\u6db2\u5747\u8d2d\u81ea\u7f8e\u56fdMedChemExpress\u516c\u53f8\u3002Mueller-Hinton(MH)\u8089\u6c64\u548c\u80f0\u86cb\u767d\u80e8\u5927\u8c46\u8089\u6c64(tryptone soy broth\uff0cTSB)\u5747\u8d2d\u81ea\u5317\u4eac\u7d22\u83b1\u5b9d\u79d1\u6280\u6709\u9650\u516c\u53f8\u3002ATP\u589e\u5f3a\u578b\u8bd5\u5242\u76d2\u8d2d\u81ea\u4e0a\u6d77\u78a7\u4e91\u5929\u751f\u7269\u6280\u672f\u6709\u9650\u516c\u53f8\u3002\u7f8a\u8840\u743c\u8102\u5e73\u677f\u8d2d\u81ea\u90d1\u5dde\u5b89\u56fe\u751f\u7269\u79d1\u6280\u6709\u9650\u516c\u53f8\u300296\u5b54\u7ec6\u80de\u57f9\u517b\u677f\u548c50 mL\u79bb\u5fc3\u7ba1\u5747\u8d2d\u81ea\u7f8e\u56fd\u5eb7\u5b81\u516c\u53f8\u3002\u5168\u81ea\u52a8\u9ea6\u6c0f\u6bd4\u6d4a\u4eea\u8d2d\u81ea\u6cd5\u56fd\u6885\u91cc\u57c3\u516c\u53f8\u3002\u6052\u6e29\u6447\u5e8a\u3001\u6052\u6e29\u57f9\u517b\u7bb1\u548c-80 \u2103\u4f4e\u6e29\u51b0\u7bb1\u8d2d\u81ea\u7f8e\u56fd\u8d5b\u9ed8\u98de\u516c\u53f8\u3002Bio-tek\u5168\u81ea\u52a8\u9176\u6807\u4eea\u5747\u8d2d\u81ea\u7f8e\u56fd\u4f2f\u4e50\u516c\u53f8\u3002\u900f\u5c04\u7535\u955c\u8d2d\u81ea\u65e5\u672c\u65e5\u7acb\u516c\u53f8\u3002\u6fc0\u5149\u5171\u805a\u7126\u663e\u5fae\u955c\u8d2d\u81ea\u5fb7\u56fd\u8521\u53f8\u516c\u53f8\u3002\n\n## \u83cc\u682a\u6536\u96c6\u53ca\u4fdd\u5b58\n\u8868\u76ae\u8461\u8404\u7403\u83cc\u6807\u51c6\u83cc\u682aRP62A\u8d2d\u81ea\u7f8e\u56fd\u6807\u51c6\u83cc\u682a\u6536\u85cf\u4e2d\u5fc3\u3002\u8868\u76ae\u8461\u8404\u7403\u83cc\u4e34\u5e8a\u83cc\u682aSEP101\u3001SEP102\u3001SEP103\u3001SEP104\u3001SEP105\u3001SEP106\u3001SEP107\u548cSEP108\u5747\u4e8e2022\u5e741\u81f39\u6708\u6536\u96c6\u81ea\u4e2d\u5357\u5927\u5b66\u6e58\u96c5\u4e09\u533b\u9662\u68c0\u9a8c\u79d1\u4f4f\u9662\u60a3\u8005\u7684\u8840\u6db2\u6807\u672c\u3002\u7ec6\u83cc\u7ecf\u7f8a\u8840\u743c\u8102\u5e73\u677f\u5206\u7eaf\u57f9\u517b\uff0c\u5e76\u901a\u8fc7\u57fa\u8d28\u8f85\u52a9\u6fc0\u5149\u89e3\u6790\u7535\u79bb-\u98de\u884c\u65f6\u95f4\u8d28\u8c31\u8fdb\u884c\u9274\u5b9a\u3002\u6240\u6709\u83cc\u682a\u5747\u4e8e\u7518\u6cb9\u78c1\u73e0\u4e2d\u63a5\u79cd\uff0c-80 \u2103\u4fdd\u5b58\uff0c\u5728\u7f8a\u8840\u743c\u8102\u5e73\u677f\u4e0a\u4f20\u4ee32\u6b21\u540e\u8fdb\u884c\u540e\u7eed\u5b9e\u9a8c\u3002\n\n## \u5fae\u91cf\u8089\u6c64\u7a00\u91ca\u5b9e\u9a8c\n\u6311\u53d6\u7f8a\u8840\u743c\u8102\u5e73\u677f\u4e0a\u7684\u65b0\u9c9c\u83cc\u843d\u4e8e\u65e0\u83cc\u751f\u7406\u76d0\u6c34\u4e2d\uff0c\u7528\u9ea6\u6c0f\u6bd4\u6d4a\u4eea\u8c03\u81f30.5\u9ea6\u6c0f\u6d4a\u5ea6(McFarland\uff0cMcF)\uff0c\u518d\u7528MH\u8089\u6c64\u63091\ua789100\u7a00\u91ca\u540e\u5907\u7528\u3002\u541196\u5b54\u677f\u4e2d\u6bcf\u5b54\u5206\u522b\u52a0\u516550 \u03bcL\u7528MH\u8089\u6c64\u8fdb\u884c\u500d\u6bd4\u7a00\u91ca\u81f30.031 3~32.000 0 \u03bcg/mL PVB\u548c/\u6216OXA\uff0c\u518d\u5206\u522b\u52a0\u516550 \u03bcL\u5907\u7528\u83cc\u60ac\u6db2\u3002DMSO\u8bbe\u4e3a\u9634\u6027\u5bf9\u7167\u3002\u5c0696\u5b54\u677f\u653e\u7f6e\u4e8e\u6e7f\u76d2\u4e2d\uff0c\u4e8e37 \u2103\u6052\u6e29\u5b75\u80b2\u7bb1\u4e2d\u9759\u7f6e\u57f9\u517b16~18 h\u3002\u8bfb\u53d6\u6700\u4f4e\u6291\u83cc\u6d53\u5ea6(minimal inhibitory concentration\uff0cMIC)\uff0c\u5373\u6291\u5236\u7ec6\u83cc\u589e\u6b96\u7684\u6700\u4f4e\u6297\u83cc\u836f\u7269\u6d53\u5ea6[8]\u3002\n\n## \u68cb\u76d8\u7a00\u91ca\u5b9e\u9a8c\n\u6311\u53d6\u65b0\u9c9c\u83cc\u843d\u4e8eTSB\u4e2d\uff0c\u4e8e37 \u2103\u4e0b\u4ee5180 r/min\u6447\u83cc\u57f9\u517b2~4 h\u81f3\u5bf9\u6570\u751f\u957f\u671f\uff0c\u5e76\u7528\u9ea6\u6c0f\u6bd4\u6d4a\u4eea\u8c03\u81f30.5 McF\uff0c\u7528MH\u8089\u6c64\u63091\ua789100\u7a00\u91ca\u540e\u5907\u7528\u3002\u7528\u65b0\u9c9cMH\u8089\u6c64\u5c06PVB\u500d\u6bd4\u7a00\u91ca\u81f30.25~16.00 \u03bcg/mL\uff0c\u7528\u5907\u7528\u83cc\u60ac\u6db2\u5c06OXA\u500d\u6bd4\u7a00\u91ca\u81f30.031 3~2.000 0 \u03bcg/mL\uff0c\u541196\u5b54\u677f\u4e2d\u6bcf\u5b54\u5206\u522b\u52a0\u516550 \u03bcL\u7a00\u91ca\u540e\u7684PVB\u548c/\u6216OXA\u3002\u5c0696\u5b54\u677f\u8f7b\u8f7b\u6df7\u5300\u540e\u7f6e\u4e8e\u6e7f\u76d2\u4e2d\uff0c\u572837 \u2103\u6052\u6e29\u5b75\u80b2\u7bb1\u4e2d\u9759\u7f6e\u57f9\u517b16~18 h\u3002\u6839\u636e\u6d4a\u5ea6\u8bfb\u53d6\u8054\u7528\u540e\u7684MIC\u503c\u6216\u7528\u9176\u6807\u4eea\u68c0\u6d4b630 nm\u5904\u7684\u5438\u5149\u5ea6(absorbance\uff0cA)\uff0c\u5e76\u8ba1\u7b97\u534f\u540c\u6291\u83cc\u6307\u6570(fractional inhibitory concentration index\uff0cFICI)\uff0c\u516c\u5f0f\u4e3aFICI=(MICA\u8054\u7528B/MICA\u5355\u7528)+(MICA\u8054\u7528B/MICB\u5355\u7528)\u3002FICI\u22640.5\u4e3a\u534f\u540c\u4f5c\u7528\uff0c0.5<FICI\u22644\u4e3a\u65e0\u5173\u4f5c\u7528\uff0cFICI>4\u4e3a\u62ee\u6297\u4f5c\u7528[9]\u3002\n\n## \u65f6\u95f4-\u6740\u83cc\u66f2\u7ebf\n\u5c06\u5bf9\u6570\u751f\u957f\u671f\u7684\u8868\u76ae\u8461\u8404\u7403\u83ccRP62A\u7528\u9ea6\u6c0f\u6bd4\u6d4a\u4eea\u8c03\u81f30.5 McF\uff0c\u5e76\u7528MH\u8089\u6c64\u63091\ua789100\u8fdb\u884c\u7a00\u91ca\uff0c\u541150 mL\u79bb\u5fc3\u7ba1\u4e2d\u6bcf\u7ba1\u52a0\u516510 mL\uff0c\u518d\u5411\u5404\u7ba1\u4e2d\u5206\u522b\u52a0\u5165\u4e9a\u6291\u83cc\u6d53\u5ea6\u7684PVB\u3001OXA\u548cPVB+OXA\uff0c\u4f7fPVB\u548cOXA\u7684\u7ec8\u6d53\u5ea6\u5206\u522b\u4e3a1/4\u00d7MIC\u3002\u5c06\u79bb\u5fc3\u7ba1\u653e\u7f6e\u4e8e37 \u2103\u6052\u6e29\u6447\u5e8a\u4e0a\u4ee5180 r/min\u6447\u83cc\u57f9\u517b\uff0c\u5e76\u5206\u522b\u4e8e0\u30012\u30014\u30018\u300112\u548c24 h\u5438\u53d6100 \u03bcL\u83cc\u60ac\u6db2\u8fdb\u884c\u5e73\u677f\u7a00\u91ca\u83cc\u843d\u8ba1\u6570\u3002\u7ed8\u5236\u65f6\u95f4-\u6740\u83cc\u66f2\u7ebf[10]\u3002\n\n## \u8010\u836f\u7b5b\u9009\u5b9e\u9a8c\n\u901a\u8fc7\u836f\u654f\u8bd5\u9a8c\u68c0\u6d4bPVB\u548cOXA\u7684MIC\uff0c\u5c061/2\u00d7MIC\u5b54\u4e2d\u7684\u83cc\u60ac\u6db2\u548cMH\u8089\u6c64\u63091\ua7891 000\u500d\u7a00\u91ca\u540e\uff0c\u541196\u5b54\u677f\u4e2d\u6bcf\u5b54\u52a0\u516550 \u03bcL\u7a00\u91ca\u540e\u83cc\u60ac\u6db2\u3002\u518d\u5411\u6bcf\u5b54\u5206\u522b\u52a0\u516550 \u03bcL\u7528MH\u8089\u6c64\u5206\u522b\u500d\u6bd4\u7a00\u91ca\u81f31/16-8\u00d7MIC\u7684PVB\u548c/\u6216OXA\uff0c\u8f7b\u8f7b\u6df7\u5300\u540e\u7f6e\u4e8e\u6e7f\u76d2\u4e2d\uff0c\u572837 \u2103\u4e0b\u6052\u6e29\u5b75\u80b224 h\u3002\u8bb0\u5f55MIC\u503c\uff0c\u5e76\u5c061/2\u00d7MIC\u5b54\u4e2d\u7684\u83cc\u60ac\u6db2\u63091\ua7891 000\u500d\u7a00\u91ca\u540e\u7ee7\u7eed\u8fdb\u884cMIC\u68c0\u6d4b\u3002\u5982\u6b64\u5f80\u590d\u76d1\u6d4b15 d\uff0c\u8bb0\u5f55\u6bcf\u5929\u7684MIC\u503c[11]\u3002\n\n## \u751f\u7269\u88ab\u819c\u6e05\u9664\u5b9e\u9a8c\n\u6311\u53d6\u65b0\u9c9c\u83cc\u843d\u4e8eTSB\u4e2d\uff0c\u4e8e37 \u2103\u4ee5180 r/min\u6447\u83cc\u57f9\u517b24 h\u81f3\u5e73\u53f0\u671f\u3002\u5c06\u83cc\u60ac\u6db2\u7528\u65b0\u9c9cTSB\u63091\ua789200\u7a00\u91ca\u540e\uff0c\u541196\u5b54\u677f\u4e2d\u6bcf\u5b54\u52a0\u5165200 \u03bcL\u3002\u4e8e37 \u2103\u9759\u7f6e\u5b75\u80b224 h\uff0c\u4f7f\u5176\u5f62\u6210\u751f\u7269\u88ab\u819c\u3002\u5f03\u53bb\u4e0a\u6e05\uff0c\u6bcf\u5b54\u52a0\u5165200 \u03bcL\u751f\u7406\u76d0\u6c34\uff0c\u6f02\u6d173\u6b21\u3002\u7136\u540e\u6bcf\u5b54\u52a0\u5165200 \u03bcL\u7528TSB\u7a00\u91ca\u540e\u7684PVB\u548c/\u6216OXA\uff0c\u7136\u540e\u4e8e37 \u2103\u7ee7\u7eed\u5b75\u80b224 h\u540e\u5f03\u53bb\u4e0a\u6e05\uff0c\u7528\u751f\u7406\u76d0\u6c34\u6f02\u6d173\u6b21\u540e\u5f03\u4e0a\u6e05\u3002\u6bcf\u5b54\u518d\u5206\u522b\u52a0\u5165200 \u03bcL 0.25%(w/v)\u7ed3\u6676\u7d2b\u67d3\u6db2\uff0c\u4e8e\u5ba4\u6e29\u4e0b\u9759\u7f6e\u5b75\u80b215 min\u540e\u5f03\u4e0a\u6e05\uff0c\u7528\u751f\u7406\u76d0\u6c34\u6f02\u6d173\u6b21\u3002\u5f85\u667e\u5e72\u540e\u68c0\u6d4b570 nm\u5904\u7684A\u503c\uff0c\u5373\u4e3a\u751f\u7269\u88ab\u819c\u7684\u76f8\u5bf9\u91cf[11]\u3002\n\n## \u6fc0\u5149\u5171\u805a\u7126\u663e\u5fae\u955c\u89c2\u5bdf\u751f\u7269\u88ab\u819c\u5f62\u6001\n\u5c06\u57f9\u517b\u81f3\u5bf9\u6570\u751f\u957f\u671f\u7684\u8868\u76ae\u8461\u8404\u7403\u83ccRP62A\u7528\u65b0\u9c9cTSB\u63091\ua789200\u7a00\u91ca\u540e\uff0c\u54116\u5b54\u677f\u4e2d\u6bcf\u5b54\u52a0\u51652 mL\uff0c\u518d\u52a0\u5165\u4e00\u575710 mm\u00d710 mm\u65e0\u83cc\u76d6\u73bb\u7247\u3002\u5c066\u5b54\u677f\u7f6e\u4e8e37 \u2103\u6052\u6e29\u57f9\u517b\u7bb1\u4e2d\u9759\u7f6e\u5b75\u80b224 h\u6784\u5efa\u751f\u7269\u88ab\u819c\u3002\u7528PBS\u8f7b\u8f7b\u6f02\u6d173\u6b21\uff0c\u4ee5\u53bb\u9664\u672a\u4e0e\u73bb\u7247\u7ed3\u5408\u7684\u6d6e\u6e38\u83cc\uff0c\u6bcf\u5b54\u518d\u5206\u522b\u52a0\u51651\u00d7MIC\u6d53\u5ea6\u7684PVB\u548c/\u6216OXA\u3002\u52a0\u6709DMSO\u7684\u5b54\u8bbe\u7f6e\u4e3a\u5bf9\u7167\u3002\u5c066\u5b54\u677f\u653e\u7f6e\u6052\u6e29\u57f9\u517b\u7bb1\u4e2d\u4e8e37 \u2103\u4e0b\u7ee7\u7eed\u5b75\u80b224 h\uff0c\u7528PBS\u6f02\u6d173\u6b21\u540e\uff0c\u5411\u6bcf\u5757\u73bb\u7247\u4e0a\u5206\u522b\u6ef4\u52a0\u6570\u6ef410 \u03bcmol/L\u7684SYTO9/PI(\u4f53\u79ef\u6bd41\ua7891)\u6df7\u5408\u6db2\u3002\u7f6e\u4e8e4 \u2103\u4e0b\u907f\u5149\u5b75\u80b215 min\uff0c\u7528PBS\u6f02\u6d17\u6389\u591a\u4f59\u7684\u8367\u5149\u67d3\u6db2\uff0c\u901a\u8fc7\u6fc0\u5149\u5171\u805a\u7126\u663e\u5fae\u955c\u89c2\u5bdf\u751f\u7269\u88ab\u819c\u7684\u5f62\u6001\u7ed3\u6784[10]\u3002\n\n## \u6301\u7559\u83cc\u8ba1\u6570\u5b9e\u9a8c\n\u5c06RP62A\u6447\u83cc\u57f9\u517b\u81f3\u5e73\u53f0\u671f\uff0c\u7528TSB\u63091\ua789200\u7a00\u91ca\u540e\uff0c\u541196\u5b54\u677f\u4e2d\u6bcf\u5b54\u52a0\u5165200 \u03bcL\uff0c\u4e8e37 \u2103\u4e0b\u9759\u7f6e\u5b75\u80b224 h\u6784\u5efa\u751f\u7269\u88ab\u819c\u3002\u5f03\u53bb\u4e0a\u6e05\uff0c\u6bcf\u5b54\u5206\u522b\u52a0\u5165200 \u03bcL \u542b\u6709100 \u03bcg/mL\u7684\u4e07\u53e4\u9709\u7d20\u3002\u4e8e37 \u2103\u4e0b\u5b75\u80b24 h\u540e\u5f03\u4e0a\u6e05\uff0c\u6bcf\u5b54\u518d\u5206\u522b\u52a0\u5165PVB\u6216OXA\u6216\u4e24\u8005\u8054\u7528\u3002\u5206\u522b\u4e8e0\u30011\u30012\u30013\u548c4 h\u7528\u79fb\u6db2\u5668Tip\u5934\u6253\u6563\u751f\u7269\u88ab\u819c\uff0c\u5145\u5206\u6df7\u5300\u540e\uff0c\u5438\u53d6100 \u03bcL\u8fdb\u884c\u5e73\u677f\u7a00\u91ca\u83cc\u843d\u8ba1\u6570[12]\u3002\n\n## \u900f\u5c04\u7535\u955c\u89c2\u5bdf\n\u5c06\u8868\u76ae\u8461\u8404\u7403\u83ccRP62A\u5728TSB\u8089\u6c64\u4e2d\u57f9\u517b2~4 h\u81f3\u5bf9\u6570\u751f\u957f\u671f\uff0c\u4ee54 000 g\u79bb\u5fc38 min\u53d6\u6c89\u6dc0\u3002\u75281\u00d7PBS(pH=7.4)\u6d17\u6da4\u6c89\u6dc02\u6b21\u540e\uff0c\u52a0\u51655\u00d7MIC PVB\uff0c\u4e8e37 \u2103\u4e0b\u6447\u83cc\u5b75\u80b21 h\u3002\u518d\u4ee54 000 g\u79bb\u5fc38 min\u6536\u96c6\u6c89\u6dc0\uff0c\u52a0\u51651 mL\u620a\u4e8c\u919b\u56fa\u5b9a\u6837\u54c1\uff0c\u5e76\u75280.1 mol/L\u4e8c\u7532\u9170\u4e8c\u7532\u9178\u7f13\u51b2\u6db2\u6d17\u6da4\u6c89\u6dc0\u3002\u75281%\u56db\u6c27\u5316\u9507/1.5%\u4e9a\u94c1\u6c30\u5316\u94be\u56fa\u5b9a1 h\u540e\u6d17\u6da4\uff0c\u5e76\u5728\u542b\u67091%\u4e59\u9178\u94c0\u9170\u7684\u9a6c\u6765\u9178\u7f13\u51b2\u6db2\u4e2d\u5b75\u80b21 h\u3002\u5728\u6c34\u4e2d\u6d17\u6da42\u6b21\u540e\uff0c\u7528\u4e59\u9187\u68af\u5ea6\u6d53\u5ea6\u8131\u6c34\uff0c\u5728\u73af\u6c27\u4e19\u70f7\u4e2d\u5b75\u80b21 h\u540e\u8fdb\u884c\u5305\u57cb\uff0c\u5e76\u572860 \u2103\u4e0b\u805a\u540848 h\u3002\u5728\u5207\u7247\u673a\u4e0a\u5207\u5272\u8d85\u8584\u5207\u7247\uff0c\u6536\u96c6\u4e8e\u94dc\u7f51\u683c\u4e0a\uff0c\u7528\u67e0\u6aac\u9178\u94c5\u67d3\u8272\u3002\u91c7\u7528\u900f\u5c04\u7535\u955c\u89c2\u5bdf\u7ec6\u83cc\u8d85\u5fae\u7ed3\u6784[13]\u3002\n\n## ROS\u5b9a\u91cf\u5b9e\u9a8c\n\u7528H2DCFDA\u63a2\u9488\u68c0\u6d4bROS\u3002\u5c06\u8868\u76ae\u8461\u8404\u7403\u83ccRP62A\u5728TSB\u8089\u6c64\u4e2d\u57f9\u517b2~4 h\u81f3\u5bf9\u6570\u751f\u957f\u671f\uff0c\u6d17\u6da4\u5e76\u91cd\u60ac\u57281\u00d7PBS\u4e2d\u81f3A600 nm=0.5\u3002\u5c06\u7ec6\u83cc\u60ac\u6d6e\u6db2\u4e0e 10 \u03bcmol/L H2DCFDA\u907f\u5149\u5b75\u80b230 min\u3002\u518d\u7528PBS\u6d17\u6da42\u6b21\u540e\uff0c\u5c0610 \u03bcL PVB\u6216OXA\u6216PVB+OXA\u52a0\u516590 \u03bcL\u5236\u5907\u7684\u7ec6\u83cc\u60ac\u6d6e\u6db2\u4e2d\u5b75\u80b230 min\u3002\u968f\u540e\uff0c\u5728\u6fc0\u53d1\u6ce2\u957f488 nm\u548c\u68c0\u6d4b\u6ce2\u957f525 nm\u4e0b\u68c0\u6d4b\u8367\u5149\u5f3a\u5ea6[14]\u3002\n\n## ATP\u5b9a\u91cf\u5b9e\u9a8c\n\u5c06\u8868\u76ae\u8461\u8404\u7403\u83ccRP62A\u5728TSB\u8089\u6c64\u4e2d\u57f9\u517b2~4 h\u81f3\u5bf9\u6570\u751f\u957f\u671f\uff0c\u6d17\u6da4\u540e\u91cd\u60ac\u4e8e1\u00d7PBS\u4e2d\u5e76\u8c03\u8282\u81f3 A600 nm=0.5\u3002\u7528PVB\u6216OXA\u6216PVB+OXA\u5904\u74061 h\u540e\uff0c\u4e8e4 \u2103\u4e0b\u4ee54 000 g\u79bb\u5fc38 min\u53d6\u6c89\u6dc0\u3002\u5206\u522b\u52a0\u5165100 \u03bcL\u81f396\u5b54\u677f\u4e2d\uff0c\u518d\u5206\u522b\u52a0\u5165100 \u03bcL\u5de5\u4f5c\u6db2\uff0c\u91c7\u7528\u9176\u6807\u4eea\u68c0\u6d4b\u8367\u5149\u5f3a\u5ea6[15]\u3002\n\n## \u7edf\u8ba1\u5b66\u5904\u7406\n\u91c7\u7528GraphPad Prism 8.0\u7edf\u8ba1\u5b66\u8f6f\u4ef6\u8fdb\u884c\u5206\u6790\u3002\u8ba1\u91cf\u8d44\u6599\u91c7\u7528\u5747\u6570\u00b1\u6807\u51c6\u5dee(\nx\u00af\n\u00b1s)\u8868\u793a\u30022\u7ec4\u6bd4\u8f83\u91c7\u7528Student\u2019s t\u68c0\u9a8c\uff0c\u591a\u7ec4\u6bd4\u8f83\u91c7\u7528\u5355\u56e0\u7d20\u65b9\u5dee\u5206\u6790(analysis of variance\uff0cANOVA)\u3002P<0.05\u4e3a\u5dee\u5f02\u6709\u7edf\u8ba1\u5b66\u610f\u4e49\u3002\n\n## \n\n\u901a\u8fc7\u5fae\u91cf\u8089\u6c64\u7a00\u91ca\u5b9e\u9a8c\u6d4b\u5f97RP62A\u5bf9PVB\u548cOXA\u7684MIC\u5747\u4e3a8 \u03bcg/mL\u3002\u68cb\u76d8\u7a00\u91ca\u5b9e\u9a8c\u663e\u793aPVB\u4e0eOXA\u8054\u7528\u5177\u6709\u660e\u663e\u7684\u534f\u540c\u6297\u83cc\u4f5c\u7528\uff0c\u5176FICI\u4e3a0.25(\u56fe1A)\u3002\u8fdb\u4e00\u6b65\u901a\u8fc7\u65f6\u95f4-\u6740\u83cc\u66f2\u7ebf\u53d1\u73b01/4\u00d7MIC\u7684PVB\u6216OXA\u5bf9\u8868\u76ae\u8461\u8404\u7403\u83cc\u65e0\u6740\u83cc\u4f5c\u7528\u6216\u4ec5\u6709\u8f7b\u5fae\u7684\u6740\u83cc\u4f5c\u7528\uff1b\u5f53\u4e24\u836f\u8054\u7528\u65f6\uff0c\u53ef\u663e\u8457\u51cf\u5c11\u6d3b\u83cc\u6570\u91cf\uff0c\u4f5c\u752812 h\u5373\u53ef\u5b8c\u5168\u6740\u706d\u8868\u76ae\u8461\u8404\u7403\u83cc\uff0c\u4e14\u6291\u5236\u6548\u679c\u957f\u8fbe24 h(\u56fe1B)\u3002\u6b64\u5916\uff0cPVB\u4e0eOXA\u8054\u7528\u5bf9\u4e34\u5e8a\u5206\u79bb\u83cc\u682a\u5747\u6709\u660e\u663e\u7684\u534f\u540c\u4f5c\u7528\uff0c\u5176FICI\u4e3a0.187 5~0.500 0(\u88681)\u3002\n\n## \n\n\u5fae\u91cf\u8089\u6c64\u7a00\u91ca\u5b9e\u9a8c\u6d4b\u5f97\u73af\u4e19\u6c99\u661f(ciprofloxacin\uff0cCIP)\u5bf9RP62A\u7684MIC\u4e3a0.5 \u03bcg/mL\u3002\u4e9a\u6291\u83cc\u6d53\u5ea6CIP\u8fde\u7eed\u8bf1\u5bfc15 d\uff0c\u53ef\u4f7fCIP\u7684MIC\u4e0a\u534764\u500d\u3002\u5373\u4f7f\u4e9a\u6291\u83cc\u6d53\u5ea6\u7684PVB\u8fde\u7eed\u8bf1\u5bfc15 d\uff0c\u5176\u5bf9RP62A\u7684MIC\u59cb\u7ec8\u7ef4\u6301\u57288 \u03bcg/mL\u3002\u4e9a\u6291\u83cc\u6d53\u5ea6\u7684OXA\u4e0e\u8868\u76ae\u8461\u8404\u7403\u83cc\u4f5c\u752815 d\uff0c\u53ef\u4f7f\u5176MIC\u4e0a\u534716\u500d\uff0c\u800c\u5f53OXA\u4e2d\u52a0\u51651/8\u00d7MIC\u7684PVB\u65f6\uff0c\u53ef\u663e\u8457\u6291\u5236OXA\u5f15\u8d77\u7684\u8010\u836f\uff0c\u4f7fOXA\u7684MIC\u59cb\u7ec8\u7ef4\u6301\u57280.5 \u03bcg/mL(\u56fe2)\u3002\n\n## \n\n1/2\u00d7MIC\u7684PVB\u62161\u00d7MIC OXA\u5bf9\u8868\u76ae\u8461\u8404\u7403\u83cc\u5df2\u5f62\u6210\u7684\u751f\u7269\u88ab\u819c\u65e0\u6e05\u9664\u4f5c\u7528\uff0c\u800c\u5f53\u4e24\u8005\u8054\u7528\u65f6\uff0c\u53ef\u4f7f\u751f\u7269\u88ab\u819c\u7684\u603b\u91cf\u4ece(2.36\u00b10.46)\u51cf\u5c11\u5230(1.12\u00b10.39) (t=3.504\uff0cP=0.02\uff1b\u56fe3A)\u3002SYTO9/PI\u8367\u5149\u67d3\u8272\u53d1\u73b0\uff1a\u7528PVB\u5355\u72ec\u5904\u7406\u8868\u76ae\u8461\u8404\u7403\u83cc\u751f\u7269\u88ab\u819c\u65f6\u4ec5\u6709\u5fae\u5f31\u7684\u6e05\u9664\u4f5c\u7528\uff0c\u5355\u7528OXA\u65f6\u65e0\u6297\u751f\u7269\u819c\u4f5c\u7528\uff0c\u800c\u5f53\u4e24\u8005\u8054\u7528\u65f6\uff0c\u53ef\u660e\u663e\u964d\u4f4e\u751f\u7269\u88ab\u819c\u603b\u91cf\uff0c\u589e\u52a0\u6b7b\u4ea1\u7ec6\u83cc\u6bd4\u4f8b(\u56fe3B)\uff0c\u5373\u603b\u4f53\u5f31\u8367\u5149\u5f3a\u5ea6\u964d\u4f4e(\u56fe3C)\uff0c\u7ea2\u8272\u8367\u5149\u6bd4\u4f8b\u589e\u52a0(\u56fe3D)\u3002PVB\u548cOXA\u8054\u7528\u8fd8\u53ef\u534f\u540c\u51cf\u5c11\u751f\u7269\u88ab\u819c\u4e2d\u7684\u6301\u7559\u83cc\u6570\u91cf\uff0c\u4e14\u968f\u7740\u4f5c\u7528\u65f6\u95f4\u5ef6\u957f\uff0c\u5176\u6297\u83cc\u6548\u679c\u66f4\u4f73\u3002\u5f53PVB\u8054\u7528OXA\u4f5c\u7528\u4e8e\u6301\u7559\u83cc 4 h\u65f6\uff0c\u53ef\u4f7f\u6301\u7559\u83cc\u7684\u603b\u91cf\u4ecelg(7.73\u00b10.21)\u51cf\u5c11\u5230lg(2.79\u00b10.43) (t=4.143\uff0cP=0.014\uff1b\u56fe3E)\u3002\u9009\u53d64\u682a\u4e34\u5e8a\u5206\u79bb\u83cc\u682a\u5bf9PVB\u8054\u7528OXA\u7684\u534f\u540c\u6297\u751f\u7269\u88ab\u819c\u6548\u679c\u8fdb\u884c\u9a8c\u8bc1\uff0c\u53d1\u73b0\u5355\u72ec\u4f7f\u7528OXA\u4e0d\u80fd\u6216\u4ec5\u8f7b\u5ea6\u6e05\u9664\u4e34\u5e8a\u83cc\u682a\u8868\u76ae\u8461\u8404\u7403\u83cc\u751f\u7269\u88ab\u819c\uff0c\u5f53\u52a0\u51651/8\u00d7MIC\u7684PVB\u65f6\uff0c\u53ef\u663e\u8457\u63d0\u9ad8OXA\u5bf9\u751f\u7269\u88ab\u819c\u7684\u6e05\u9664\u80fd\u529b(\u56fe4)\u3002\n\n## \n\n\u900f\u5c04\u7535\u955c\u89c2\u5bdf\u53d1\u73b0PVB\u53ef\u660e\u663e\u7834\u574f\u8868\u76ae\u8461\u8404\u7403\u83cc\u6b63\u5e38\u7ec6\u80de\u7ed3\u6784\uff0c\u4f7f\u7ec6\u80de\u58c1\u574d\u584c\uff0c\u7ec6\u80de\u5185\u5bb9\u7269\u5916\u6392\u6d88\u5931\uff0c\u4e14\u7ec6\u80de\u819c\u805a\u96c6\u6210\u56ca\u6ce1\u72b6(\u56fe5A\uff0c5B)\u3002\u8fd9\u53ef\u80fd\u662fPVB\u7834\u574f\u4e86\u7ec6\u83cc\u80fd\u91cf\u7684\u4ea7\u751f\uff0c\u4ece\u800c\u65e0\u6cd5\u7ef4\u6301\u7ec6\u80de\u5185\u5916\u6e17\u900f\u538b\u3002ROS\u5b9a\u91cf\u53d1\u73b0\uff1aPVB\u5355\u72ec\u4f7f\u7528\u5373\u53ef\u4fc3\u8fdbROS\u7684\u5f62\u6210\uff0c\u5f53OXA\u4e0ePVB\u8054\u7528\u65f6\uff0c\u5219\u53ef\u663e\u8457\u4fc3\u8fdb\u7ec6\u83cc\u4ea7\u751fROS\uff0c\u4f7f\u5176\u76f8\u5bf9\u8367\u5149\u5f3a\u5ea6\u4ece(29 966.67\u00b11 903.51)\u5347\u9ad8\u5230(45 666.67\u00b12 081.67) (t=10.420\uff0cP<0.001\uff1b\u56fe5C)\u3002\u8fdb\u4e00\u6b65\u901a\u8fc7ATP\u68c0\u6d4b\u53d1\u73b0PVB\u548cOXA\u8054\u7528\u53ef\u663e\u8457\u964d\u4f4eATP\u7684\u751f\u6210\uff0c\u4f7fATP\u7684\u5408\u6210\u91cf\u4ece(565\u00b133.18)\u51cf\u5c11\u5230(205.67\u00b135.23) (t=4.932\uff0cP=0.003\uff1b\u56fe5D)\u3002\u56e0\u6b64\uff0cPVB\u8054\u7528OXA\u7684\u6297\u83cc\u673a\u5236\u53ef\u80fd\u6d89\u53caROS\u7684\u4ea7\u751f\u589e\u591a\u548cATP\u7684\u5408\u6210\u51cf\u5c11\u3002\n\n## \u8ba8 \u8bba\n\u8868\u76ae\u8461\u8404\u7403\u83cc\u6613\u9ecf\u9644\u4e8e\u533b\u7597\u5668\u68b0\u8868\u9762\u5f62\u6210\u8010\u836f\u6027\u6781\u9ad8\u7684\u751f\u7269\u88ab\u819c\uff0c\u53ef\u968f\u7740\u4fb5\u5165\u6027\u64cd\u4f5c\u8fdb\u5165\u4eba\u4f53\u800c\u5f15\u53d1\u611f\u67d3\u3002\u76ee\u524d\uff0c\u5c1a\u65e0\u6709\u6548\u6297\u751f\u7d20\u80fd\u6e05\u9664\u5df2\u5f62\u6210\u7684\u751f\u7269\u88ab\u819c\u3002\u56e0\u6b64\uff0c\u65b0\u578b\u6297\u83cc\u836f\u7269\u7684\u7814\u53d1\u5df2\u6210\u4e3a\u5f53\u4e0b\u70ed\u70b9\u3002\u672c\u7814\u7a76\u901a\u8fc7\u836f\u7269\u91cd\u65b0\u5229\u7528\u53d1\u73b0\u6cbb\u7597\u80a0\u6613\u6fc0\u7efc\u5408\u5f81\u836f\u7269PVB\u8054\u7528OXA\u5bf9\u8868\u76ae\u8461\u8404\u7403\u83cc\u53ca\u5176\u751f\u7269\u88ab\u819c\u548c\u6301\u7559\u83cc\u5177\u6709\u663e\u8457\u7684\u534f\u540c\u6297\u83cc\u6548\u679c\uff0c\u5e76\u901a\u8fc7\u673a\u5236\u5b9e\u9a8c\u63ed\u793aPVB\u7684\u4f5c\u7528\u673a\u5236\u4e3b\u8981\u6d89\u53caROS\u7684\u4ea7\u751f\u3002\n\u8010\u7532\u6c27\u897f\u6797\u8868\u76ae\u8461\u8404\u7403\u83cc\u7684\u6d41\u884c\u5177\u6709\u660e\u663e\u7684\u5730\u57df\u533a\u522b\uff0c\u6b27\u6d32\u56fd\u5bb6\u5360\u6bd4\u8f83\u9ad8\uff0c\u5176\u8868\u76ae\u8461\u8404\u7403\u83cc\u76f8\u5173\u611f\u67d3\u4e2d\uff0c\u8010\u7532\u6c27\u897f\u6797\u5206\u79bb\u682a\u5360\u6bd460%~70%\u3002\u957f\u65f6\u95f4\u4f4f\u9662\u3001\u6ee5\u7528\u5e7f\u8c31\u6297\u751f\u7d20\u6216\u4f7f\u7528\u591a\u79cd\u6297\u751f\u7d20\u3001\u957f\u671f\u6297\u751f\u7d20\u6cbb\u7597\u3001\u624b\u672f\u4f24\u53e3\u3001\u5e94\u7528\u533b\u7597\u5668\u68b0\u3001\u4e2d\u5fc3\u9759\u8109\u7f6e\u7ba1\u6216\u4f7f\u7528\u5bfc\u5c3f\u7ba1\u7b49\u539f\u56e0\u90fd\u80fd\u589e\u52a0\u8010\u7532\u6c27\u897f\u6797\u8868\u76ae\u8461\u8404\u7403\u83cc\u7684\u53d1\u751f\u7387[16]\u3002\u8010\u7532\u6c27\u897f\u6797\u8868\u76ae\u8461\u8404\u7403\u83cc\u5bf9OXA\u7684\u8010\u836f\u6027\u666e\u904d\u5b58\u5728[17]\u3002\u6b64\u5916\uff0cOXA\u53ef\u5f15\u8d77\u809d\u6bd2\u6027\uff0c\u5927\u5242\u91cf\u6ce8\u5c04\u8fd8\u80fd\u5bfc\u81f4\u795e\u7ecf\u6bd2\u6027[18]\u3002\u56e0\u6b64\uff0c\u5bfb\u627e\u80fd\u6709\u6548\u6539\u5584OXA\u7684\u6297\u83cc\u6d3b\u6027\u5e76\u964d\u4f4e\u5176\u8010\u836f\u6027\u7684\u4f50\u5242\u5177\u6709\u8f83\u5927\u7684\u4e34\u5e8a\u610f\u4e49\u3002\u672c\u7814\u7a76\u4e2d\uff0cPVB\u80fd\u6709\u6548\u63d0\u9ad8OXA\u7684\u6297\u83cc\u80fd\u529b\uff0c\u5e76\u663e\u8457\u6539\u5584\u5176\u8010\u836f\u5f62\u6210\u7684\u80fd\u529b\u3002\u56e0\u6b64\uff0cPVB\u6709\u671b\u6210\u4e3aOXA\u7684\u4f50\u5242\uff0c\u901a\u8fc7\u63d0\u9ad8OXA\u7684\u6297\u83cc\u80fd\u529b\u964d\u4f4eOXA\u7684\u4f7f\u7528\u5242\u91cf\uff0c\u4ece\u800c\u964d\u4f4eOXA\u7684\u6bd2\u6027\uff0c\u63d0\u9ad8\u5176\u4f7f\u7528\u4ef7\u503c\u5e76\u51cf\u5f31\u7ec6\u83cc\u8010\u836f\u6027\uff0c\u589e\u5f3a\u4e34\u5e8a\u5b9e\u7528\u6027\u3002\n\u4e0e\u672c\u7814\u7a76\u7c7b\u4f3c\uff0cMao\u7b49[7]\u53d1\u73b0PVB\u5bf9\u91d1\u9ec4\u8272\u8461\u8404\u7403\u83cc\u4e5f\u5177\u6709\u6740\u83cc\u6d3b\u6027\uff0c\u5176MIC50\u548cMIC90\u5206\u522b\u4e3a12.5 \u03bcmol/L(\u7ea67.39 \u03bcg/mL)\u548c25 \u03bcmol/L(\u7ea614.79 \u03bcg/mL)\u3002\u672c\u7814\u7a76\u6d4b\u5f97PVB\u5bf9\u8868\u76ae\u8461\u8404\u7403\u83cc\u7684MIC\u4e3a8 \u03bcg/mL\uff0c\u56e0\u6b64\uff0cPVB\u5bf9\u8868\u76ae\u8461\u8404\u7403\u83cc\u548c\u91d1\u9ec4\u8272\u8461\u8404\u7403\u83cc\u5177\u6709\u76f8\u4f3c\u7684\u6297\u83cc\u6d3b\u6027\u3002\u6b64\u5916\uff0cMao\u7b49[7]\u53d1\u73b0PVB\u5bf9\u91d1\u9ec4\u8272\u8461\u8404\u7403\u83cc\u7684\u751f\u7269\u819c\u548c\u6301\u7559\u83cc\u4e5f\u5177\u6709\u4e00\u5b9a\u7684\u6297\u83cc\u4f5c\u7528\uff0cPVB\u5bf9\u91d1\u9ec4\u8272\u8461\u8404\u7403\u83cc\u7684\u6297\u83cc\u673a\u5236\u4e3b\u8981\u6d89\u53ca\u7ec6\u80de\u819c\u6e17\u900f\u6027\u7684\u7834\u574f\uff0c\u800c\u672c\u7814\u7a76\u5bf9\u8868\u76ae\u8461\u8404\u7403\u83cc\u7684\u6297\u83cc\u673a\u5236\u4e3b\u8981\u6d89\u53caROS\u7684\u8bf1\u5bfc\u3002\nPVB\u662f\u4e00\u79cd\u9499\u79bb\u5b50\u901a\u9053\u963b\u65ad\u5242\uff0c\u6bd2\u526f\u4f5c\u7528\u5c0f\u4e14\u5177\u6709\u826f\u597d\u7684\u4eba\u4f53\u8010\u53d7\u6027\u3002\u4e00\u9879\u7814\u7a76[19]\u901a\u8fc7\u7eb3\u5165117\u4f8b\u6d88\u5316\u529f\u80fd\u4e0d\u826f\u7684\u60a3\u8005\uff0c\u5bf9\u6bd4PVB\u548c\u591a\u6f58\u7acb\u916e\u7684\u6cbb\u7597\u6548\u679c\u548c\u5b89\u5168\u6027\u3002\u7ed3\u679c\u663e\u793a\uff1a\u6cbb\u75974\u5468\u540e\uff0cPVB\u7ec4\u60a3\u8005\u7684\u6548\u679c\u663e\u8457\u4f18\u4e8e\u591a\u6f58\u7acb\u916e\u7ec4\uff0c\u4e14\u4e0d\u826f\u53cd\u5e94\u4e0e\u591a\u6f58\u7acb\u916e\u7ec4\u5dee\u5f02\u65e0\u7edf\u8ba1\u5b66\u610f\u4e49\uff0c\u63d0\u793aPVB\u5b89\u5168\u6027\u9ad8\u3002\u7a76\u5176\u539f\u56e0\u4e3a\uff1a\u4e00\u65b9\u9762\uff0cPVB\u7684\u8840\u6d46\u86cb\u767d\u7ed3\u5408\u7387\u9ad8\uff0c\u4e3a95%~98%\uff0c\u4ee3\u8c22\u901f\u5ea6\u5feb\uff0c\u5728\u4eba\u4f53\u4e2d\u4f5c\u7528\u7684\u65f6\u95f4\u8f83\u77ed\uff1b\u53e6\u4e00\u65b9\u9762\uff0cPVB\u7684\u5168\u8eab\u5438\u6536\u80fd\u529b\u8f83\u5dee\uff0c\u5bf9\u80c3\u80a0\u9053\u5177\u6709\u9009\u62e9\u6027\uff0c\u800c\u5bf9\u5fc3\u8840\u7ba1\u7cfb\u7edf\u57fa\u672c\u65e0\u836f\u7406\u4f5c\u7528\uff0c\u4e14PVB\u65e0\u6297\u80c6\u78b1\u80fd\u4f5c\u7528\uff0c\u56e0\u6b64\u5bf9\u5fc3\u8840\u7ba1\u7cfb\u7edf\u65e0\u6bd2\u526f\u4f5c\u7528[20-21]\u3002\nPVB\u7684\u4f5c\u7528\u673a\u5236\u4e3b\u8981\u6d89\u53caATP\u7684\u5408\u6210\u51cf\u5c11\u548cROS\u7684\u4ea7\u751f\u589e\u591a\u3002\u4fc3\u8fdbROS\u4ea7\u751f\u662f\u8bf8\u591a\u6297\u83cc\u836f\u7269\u5171\u540c\u7684\u4f5c\u7528\u673a\u5236\u3002ROS\u4e3b\u8981\u5305\u62ecO2\u2022-\u3001\u2022OH\u548c\u8fc7\u6c27\u5316\u6c22(hydrogen peroxide\uff0cH2O2)\uff0c\u8fd9\u4e9b\u6d3b\u6027\u6210\u5206\u53ef\u4ee5\u635f\u4f24\u7ec6\u80de\u7ed3\u6784\u4e2d\u7684\u5927\u5206\u5b50\uff0c\u5305\u62ec\u86cb\u767d\u8d28\u3001\u8102\u8d28\u548c\u6838\u9178\u7b49\uff0c\u6700\u7ec8\u5bfc\u81f4\u7ec6\u83cc\u6b7b\u4ea1[22]\u3002\u5982\uff0c\u7eb3\u7c73\u94f6\u53ef\u901a\u8fc7\u8bf1\u5bfc\u94dc\u7eff\u5047\u5355\u80de\u83cc\u4ea7\u751fROS\u800c\u53d1\u6325\u6740\u83cc\u4f5c\u7528[23]\uff1b\u6709\u6c27\u6761\u4ef6\u4e0b\uff0c\u7eb3\u7c73\u94dc\u53ef\u901a\u8fc7\u8bf1\u5bfcROS\u5728\u5468\u6d46\u95f4\u9699\u4e2d\u805a\u96c6\uff0c\u4ece\u800c\u4fc3\u8fdb\u86cb\u767d\u8d28\u51dd\u96c6\u800c\u53d1\u6325\u6709\u6548\u6297\u83cc\u4f5c\u7528[24]\uff1b\u8863\u5eb7\u9178\u53ef\u901a\u8fc7\u4fc3\u8fdb\u78f7\u9178\u620a\u7cd6\u4ee3\u8c22\u9014\u5f84\u800c\u4ea7\u751fROS\uff0c\u4ece\u800c\u53d1\u6325\u6297\u708e\u548c\u6297\u83cc\u7684\u4f5c\u7528[25]\u3002\u6b64\u5916\uff0c\u8fd1\u5e74\u6765\u65b0\u53d1\u73b0\u7684\u6297\u83cc\u836f\u7269\u5982\u7f9f\u57fa\u67e5\u97e6\u65af\u9187\u3001\u513f\u8336\u7d20\u3001\u6ca1\u98df\u5b50\u9178\u916f\u548c\u4e00\u4e9b\u915a\u7c7b\u7b49\u5747\u80fd\u901a\u8fc7\u8bf1\u5bfcROS\u7684\u4ea7\u751f\u800c\u53d1\u6325\u6297\u83cc\u4f5c\u7528[22]\u3002\n\u7efc\u4e0a\u6240\u8ff0\uff0cPVB\u8054\u7528OXA\u5bf9\u8868\u76ae\u8461\u8404\u7403\u83cc\u53ca\u5176\u751f\u7269\u88ab\u819c\u548c\u6301\u7559\u83cc\u5747\u5177\u6709\u663e\u8457\u7684\u534f\u540c\u6297\u83cc\u4f5c\u7528\u3002PVB\u53ef\u6291\u5236ATP\u7684\u5408\u6210\u5e76\u8bf1\u5bfcROS\u7684\u4ea7\u751f\u800c\u53d1\u6325\u6297\u83cc\u6d3b\u6027\u3002PVB\u662f\u5df2\u4e0a\u5e02\u7684\u80a0\u6613\u6fc0\u7efc\u5408\u5f81\u9996\u9009\u6cbb\u7597\u836f\u7269\uff0c\u5408\u6210\u8def\u7ebf\u6210\u719f\u4e14\u6bd2\u526f\u4f5c\u7528\u660e\u786e\uff0c\u6709\u671b\u4e0eOXA\u8054\u7528\u6210\u4e3a\u96be\u6cbb\u6027\u8868\u76ae\u8461\u8404\u7403\u83cc\u751f\u7269\u88ab\u819c\u76f8\u5173\u611f\u67d3\u7684\u66ff\u4ee3\u836f\u7269\u3002",
  "has_full_text": true
}